“…Furthermore, implementation of the EST in regulatory test guidelines would demonstrate the importance of in vitro assays as valuable components of the risk/hazard assessment process. Based on animal studies, embryocidal, multiple abnormalities (Villani et al, 1996) 3 Caffeine 20e55 81.6 Cardiac, CNS Skeletal defects, retarded growth and low birth weight (Pesce et al, 1998) 4 Indomethacin 0.5e1 4.49 Cardiac, Renal Premature closure of ductus arteriosus (Shehata et al, 2006;Hvidberg et al, 1972) 5 Penicillin G 300e500 1300 Hypersensitivity None in humans (Penicillin G) 6…”